VANCOUVER, British Columbia, Feb. 05, 2018 -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) is proud to announce that it will be working with First Nation communities from across the Province of Saskatchewan, providing valuable information and strategic business approaches surrounding the Cannabis, Medical Marijuana and Hemp industries. RavenQuest has developed an indigenous-centered, end-to-end offering for cannabis production and sale on sovereign land.
Mr. Bill Robinson, RavenQuest’s Head of Government and Indigenous Relations, and Ms. Benilda Sable responsible for RavenQuest’s Regulatory Compliance and Quality Assurance, will be meeting with numerous First Nation community representatives in Regina on February 5th, Saskatoon on February 6th and Prince Albert on February 7th, 2018.
Mr. Bill Robinson is formerly the Commanding Officer of the RCMP in Manitoba and past President and Chief Executive Officer of the Alberta Gaming and Liquor Commission. Mr. Robinson has worked closely with First Nation communities across Canada on harm reduction and addiction strategies. Mr. Robinson also heads, as the Executive Director, the Indigenous Peoples Cannabis Association. The association is designed to present a unified voice for indigenous communities.
Ms. Sable brings expertise from the food, hemp and medical marijuana industries especially liaising with Health Canada. For the past decade she has worked with a wide variety of processing facilities to ensure continued compliance with regulations. Ms. Sable is a major advisor to hemp processing facilities, domestic and abroad.
“We are honoured to be viewed as a trusted voice of the Cannabis industry in Canada. The relationships which RavenQuest has developed with First Nation communities across the country speaks to the immense amount of work we have done to develop a comprehensive turnkey cannabis solution that is tailor made for Canada’s Indigenous communities. We are very proud to be working with the First Nation Communities of Saskatchewan” said George Robinson, CEO of RavenQuest.
About RavenQuest BioMed Inc.
RavenQuest Biomed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.
On Behalf of the Board of Directors of
RAVENQUEST BIOMED INC.
"George Robinson"
Chief Executive Officer
For further information, please contact: Mathieu McDonald, Corporate Communications 1-877-282-1586
Neither Canadian Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Stock Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.
Cautionary Note Regarding Forward-Looking Statements
All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including statements with respect to the development of a licensed cannabis production facility and anticipated production from such a facility. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited to those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Anta Sports Expands Global Footprint With Strategic Puma Stake
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 



